Offer - Urjas Oil for just ₹ 1 X
Forsemer-800 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Increased Phosphate Levels in the Blood are some of its major therapeutic uses. Forsemer-800 Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Forsemer-800 Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Forsemer-800 Tablet can also lead to other problems, which have been listed below. Such side effects of Forsemer-800 Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Forsemer-800 Tablet is Unknown for pregnant women and Safe for women who are breastfeeding. In addition, Forsemer-800 Tablet's effects on the liver, heart and kidney are discussed below in the Forsemer-800 Tablet related warnings section.
Forsemer-800 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Intestinal Obstruction are examples of such conditions. Other conditions have been mentioned below in the Forsemer-800 Tablet contraindications section.
Drug interactions for Forsemer-800 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Forsemer-800 Tablet, it is important to know that it is safe while driving, and is habit-forming.
Forsemer-800 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Is the use of Forsemer-800 Tablet safe for pregnant women?
The effects of Forsemer on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Forsemer-800 Tablet safe during breastfeeding?
Forsemer is completely safe for breastfeeding women.
What is the effect of Forsemer-800 Tablet on the Kidneys?
Very few cases of side effects of Forsemer on kidney have been reported.
What is the effect of Forsemer-800 Tablet on the Liver?
Side effects of Forsemer on the liver are unknown because research on this has not been conducted yet.
What is the effect of Forsemer-800 Tablet on the Heart?
Side effects of Forsemer on heart are unknown because research on this has not been conducted yet.
If you are suffering from any of the following diseases, you should not take Forsemer-800 Tablet unless your doctor advises you to do so -
Is this Forsemer-800 Tablet habit forming or addictive?
Forsemer-800 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Forsemer-800 Tablet since it does not cause drowsiness.
Is it safe?
Forsemer-800 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Forsemer-800 Tablet for mental disorders.
Interaction between Food and Forsemer-800 Tablet
Due to the absence of research, it is difficult to say how Forsemer-800 Tablet and food will interact.
Interaction between Alcohol and Forsemer-800 Tablet
It is difficult to say anything about the effect of Forsemer-800 Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renvela (sevelamer carbonate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1134-1135